Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
Brain : a Journal of Neurology|March 8, 2018
Towards personalized therapy for multiple sclerosis: limitations of observational dataEwout W Steyerberg, Brian Claggett
Archives of Internal Medicine|January 26, 2011
Analytical issues regarding rosiglitazone meta-analysisBrian Claggett, Lee-Jen Wei
NEJM Evidence|February 6, 2024
Behind the Scenes of TOPCAT - Bending to InformMarc A Pfeffer, Brian Claggett
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple MyelomaBrian Claggett, Lu Tian, Lee-Jen Wei
JAMA Surgery|February 21, 2019
Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End PointBrian Claggett, Hajime Uno, Lee-Jen Wei
European Heart Journal|January 19, 2013
Moving beyond our comfort zoneBrian Claggett, Lee-Jen Wei, Marc A Pfeffer
The New England Journal of Medicine|March 17, 2016
Lixisenatide in Type 2 Diabetes and Acute Coronary SyndromeMarc A Pfeffer, Brian Claggett, Jeffrey L Probstfield
The Lancet. Diabetes & Endocrinology|June 25, 2017
Sacubitril/valsartan in PARADIGM-HF - Authors' replyJelena P Seferovic, Brian Claggett, Scott D Solomon, et al.
European Heart Journal|March 13, 2012
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failureDavide Castagno, Mark C Petrie, Brian Claggett, et al.
The New England Journal of Medicine|January 15, 2025
Finerenone in Heart Failure with Preserved Ejection Fraction. ReplyScott D Solomon, Brian Claggett, John J V McMurray
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
Brain : a Journal of Neurology|March 8, 2018
Towards personalized therapy for multiple sclerosis: limitations of observational dataEwout W Steyerberg, Brian Claggett
Archives of Internal Medicine|January 26, 2011
Analytical issues regarding rosiglitazone meta-analysisBrian Claggett, Lee-Jen Wei
NEJM Evidence|February 6, 2024
Behind the Scenes of TOPCAT - Bending to InformMarc A Pfeffer, Brian Claggett
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple MyelomaBrian Claggett, Lu Tian, Lee-Jen Wei
JAMA Surgery|February 21, 2019
Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End PointBrian Claggett, Hajime Uno, Lee-Jen Wei
European Heart Journal|January 19, 2013
Moving beyond our comfort zoneBrian Claggett, Lee-Jen Wei, Marc A Pfeffer
The New England Journal of Medicine|March 17, 2016
Lixisenatide in Type 2 Diabetes and Acute Coronary SyndromeMarc A Pfeffer, Brian Claggett, Jeffrey L Probstfield
The Lancet. Diabetes & Endocrinology|June 25, 2017
Sacubitril/valsartan in PARADIGM-HF - Authors' replyJelena P Seferovic, Brian Claggett, Scott D Solomon, et al.
European Heart Journal|March 13, 2012
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failureDavide Castagno, Mark C Petrie, Brian Claggett, et al.
The New England Journal of Medicine|January 15, 2025
Finerenone in Heart Failure with Preserved Ejection Fraction. ReplyScott D Solomon, Brian Claggett, John J V McMurray
Pageof 37